Navigation Links
Scale models
Date:8/22/2011

Weizmann Institute scientists have added a significant piece to the puzzle of scaling how patterns stay in sync with size as an embryo or organism grows and develops. In a new study appearing in Current Biology, Institute scientists Profs. Naama Barkai and Ben-Zion Shilo and research student Danny Ben-Zvi of the Molecular Genetics Department have shown how scaling works in developing fruit fly wings in which the vein structure stays perfectly proportioned and their findings should be applicable to many different examples of development, including human embryonic development.

The scientists knew that patterning relies on morphogens substances that are secreted by a small number of cells in the center of the developing embryo, and from there, diffuse outward. As morphogens disperse, the levels drop off in the cells further from the center, and thus the concentration relays a signal to the developing cells about their place and function in the growing organism. But such a morphogen diffuses from the center at the same rate in a small organism as in a larger one, and thus would not effect scaling on its own.

Several years ago, the researchers found a molecule in frog embryos that is synthesized at the edges and diffuses inward. This second molecule also functions as a morphogen, and it is the redistribution of this molecule that finally determines the morphogen signal each developing cell receives, in a way that takes embryo size into consideration.

Next, Barkai and Ben-Zvi created a theoretical model, called an expansion-repression model, in which an expander molecule on the growing edge aids in the distribution of the central morphogen, which eventually represses the synthesis of the expander molecule at the edge. The model suggests just how this interplay between expansion created at the edge and repression moving from the center results in a pattern built to scale.

Ben-Zvi, Barkai and Shilo have now brought the theoretical model back into the lab, carrying out experiments on fruit fly larvae, in which wing patterning already begins in small structures called wing discs.

The scientists collected fruit fly larvae of varying sizes and, using a quantitative method they developed, checked the distribution of concentrations of a morphogen called Dpp. Then, they eliminated another molecule called Pentagone which they suspected of playing the role of expander from the developing wing disc and checked again. Their findings showed that the wings in the unaltered fruit flies revealed the morphogen scaling activity predicted by the model, its signals being proportionate to wing size. In contrast, in the flies without Pentagone the Dpp morphogen was distributed in the same way in all the wings, regardless of their relative sizes. Thus, they were able to show that Pentagone is, indeed, an expansion molecule and that the expansion-repression paradigm they had formulated can be applied to such differing organisms as frogs and fruit flies.

Shilo: 'The beauty of this research lies in the way it seamlessly weaves a theoretical model into experimental biology. With this fresh, new approach to investigating scaling, rather than searching for complex molecular mechanisms, we can begin by looking for this relatively simple and universal paradigm.'


'/>"/>

Contact: Batya Greenman
news@weizmann.ac.il
972-893-43856
Weizmann Institute of Science
Source:Eurekalert

Related biology news :

1. Researchers find way to align gold nanorods on a large scale
2. 1st large-scale map of a plants protein network addresses evolution, disease process
3. Study shows small-scale fisheries impact on marine life
4. New technique yields troves of information from nanoscale bone samples
5. Patent for arrays of nanoscale electrical probes awarded to NJIT today
6. Mimicking nature at the nanoscale: Selective transport across a biomimetic nanopore
7. Pesticide impact: Comparing lab, field-scale results
8. Penn researchers help nanoscale engineers choose self-assembling proteins
9. New nanoscale imaging may lead to new treatments for multiple sclerosis
10. Atomic-scale structures of ribosome could help improve antibiotics
11. Study Shows Sutro Biopharmas Biochemical Protein Synthesis Technology Enables Rapid Production and Scale-Up of Biopharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... LONG BEACH, New York , February 7, 2017 ... formerly known as ID Global Solutions Corporation [OTC: IDGS], ... identification, identity management and electronic transaction processing services, is ... a reorganization of the Company. Effective January ... Chairman of the Board of Directors, CEO and President. ...
(Date:2/2/2017)... 2017  EyeLock LLC, a market leader of iris-based ... " What You Should Know About Biometrics in the ... authenticity is a growing concern. In traditional schemes, cryptography ... traditional authentication schemes such as username/password suffer from inherent ... offers an elegant solution to the problem of high-security ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... ... February 23, 2017 , ... BellBrook Labs is ... include an array of biochemical analyses critical for Lead Discovery. The company’s ... and SAR programs, including inhibitor potency and selectivity, mechanism of action, and inhibitor ...
(Date:2/23/2017)... ROCHESTER, Minn. , Feb. 23, 2017 /PRNewswire/ ... a new product line of oncolytic vaccinia viruses ... Genelux Corporation as part of Genelux,s proprietary, vaccinia ... "We are excited to enter into a partnership ... time, selected oncolytic vaccinia viruses for use in ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Greater Gift Initiative, ... partnership with Compass Research . GGI's mission is to advance global health and ... child in need in honor of each clinical trial volunteer. The vision of GGI ...
(Date:2/22/2017)... 22, 2017  Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet ... innovative biopharmaceutical products for companion animals, will host a live ... ET to discuss financial results from the fourth quarter and ... participants and investors may access the audio webcast ... ...
Breaking Biology Technology: